|
|
||||||||
Review |
1
Department of Radiology, The University of TexasHouston Medical School,
6431 Fannin St., Houston, TX 77030.
2
Moerser Landstr. 352, D-47802 Krefeld, Germany.
3
Department of Radiology, University of New Mexico School of Medicine, 915
Camino de Salud, Albuquerque, NM 87131-5336.
Received September 21, 2000;
accepted after revision December 12, 2000.
Address correspondence to L. K. Wagner.
Introduction
|
|
|---|
|
|
The incidence of radiation injuries is small compared with the number of procedures performed. More than 700,000 interventional cardiologic and other procedures are now performed each year [28, 29]. A serious injury can be debilitating, requiring a prolonged course of intense care that sometimes lasts for years [23, 24]. Severe skin injuries, like chronic ulceration and necrosis, are documented in 38 of the 73 cases that we reviewed [30]. Skin grafts were required in 18 patients, three of whom needed a repeated procedure after the first graft failed [23, 24] (Table 2, patient 14).
Interventionalists are often unaware of the magnitude of the radiation dose to the skin [30, 31]. Many are not aware that such injuries can even occur with modern equipment. Consequently, they, and other physicians, frequently do not recognize the injury as being related to the procedure. For this reason, an underreporting of the number of injuries from interventional work is suspected [29]. In this article we investigate the relationship between reported skin damage and known patterns of progression to assist physicians in the recognition of these injuries. We also identify factors that can help improve patient care.
Fundamental Facts About Skin Injury
|
|
|---|
Mechanisms of X-Ray Injury
Because of their neutrally charged subatomic property, X rays can penetrate
cells, releasing kinetic electrons that create an ionization track across many
cells. This focally concentrated deposition of a tiny amount of energy breaks
molecular bonds, bringing about biochemical changes in the affected cells. No
detectable temperature rise and, typically, no disturbance to the sensory
system occurs. The body's first response occurs as an internal biologic
response in dysfunctional cells. This stimulated response goes unnoticed by
the host when the biochemical changes are minor.
Deterministic Versus Stochastic Effects
Skin changes such as erythema, ulcers, telangiectasia, and dermal atrophy
are deterministic effects. Such effects occur only when the radiation dose
exceeds a certain threshold. Histologically, a minimum number of cells must be
damaged to elicit a response, the probability and severity of which increases
rapidly as the dose increases beyond the threshold. If the dose is
sufficiently large, the effect will be seen in 100% of cases. Depending on
dose, some effects may occur promptly (<24 hr); others may be delayed for
years. Skin is the organ at greatest risk because it receives the greatest
dose. The inflammatory changes after irradiation are often referred to as
radiodermatitis.
Radiation-induced cancer is a stochastic effect that may be induced at any dose; that is, no threshold dose is involved. Its severity is independent of dose, although the probability of occurrence increases as dose increases. Some authors advocate regular follow-up to detect possible malignancies in patients with high radiation doses [22]. Though radiation-induced cancer is an important potential long-term sequela of a prolonged interventional procedure, the focus of this article will be on the much-earlier-occurring deterministic effects.
Dose Rate Delivery and Fractionation
Repair of radiation damage occurs at molecular, cellular, and tissue
levels. Enzymes repair radiation-induced DNA lesions within hours.
Repopulation at the cellular level occurs within days after irradiation
[41,
43]. As a result, the rate of
dose deposition in tissue is critical to cellular repair.
Intermittent fluoroscopy and fluorography at different dose rates are often used in interventional procedures. Dose rates may vary over a wide range depending on a multitude of factors and can be between 0.01 and 1.0 Gy/min to the skin [20]. For low-dose-rate application or for fractionated delivery of high doses, sublethal cell injuries can be repaired and killed cells replaced during the entire process of dose accumulation [40,41,42,43]. For instantaneous delivery of high doses, no interim repair is possible. Protraction of the total dose, therefore, results in higher threshold doses (total cumulated dose) for both early and late deterministic effects [37].
Although intracellular repair is complete within a few hours, repopulation of the cells in the dermis and epidermis takes much longer. Animal models suggest that full recovery of the epidermis occurs by 6 weeks as long as permanent damage is not induced [37]. Skin damage responsible for early effects can be virtually eliminated in a few months [41]. However, it is uncertain whether damage responsible for late dermal effects will recover fully or whether a residual remembered injury remains, decreasing the tolerance for future irradiation [37, 41].
Fractionation of the total dose, as seen in patients undergoing several procedures separated by days or weeks, increases overall tissue tolerance, but tolerance for each subsequent individual session may decrease. For example, if the skin has not completely recovered from a previous intervention, then the dose required to produce injury from an additional future session will be lower than that for nonirradiated skin. Of 73 patients reviewed [30], 66% of the cardiology patients had more than one angioplasty in 3 years and 14% had more than two angioplasties in 3 years. This compares with 21% and 4% as reported by Pattee et al. [44] in a study of radiation risk to patients undergoing percutaneous transluminal coronary angioplasty. The greater percentage of multiple procedures involving injury suggests that previous procedures may play a role in reducing skin tolerance, as suggested by Lichtenstein et al. [4] and Søvik et al. [6].
Biology of Radiation Effects in the Skin
|
|
|---|
Threshold Doses
The threshold doses for various types of skin injuries are summarized in
Table 3. These doses represent
skin entrance doses for single-dose irradiation. The temporal patterns in
Table 3 and in the discussions
to follow should be used as reasonable guidelines, not as absolute time
frames.
|
Responses Beginning Within Days of Irradiation
Within a few hours after single doses in excess of about 2 Gy, an early
transient erythema might occur in a well-defined area matching the entrance
site of the X-ray beam. The area may look much like sunburn. This reaction
peaks at about 24 hr and subsides after approximately 48 hr. It is thought to
represent an early phase of inflammation, with hyperemia and increased
permeability of the capillaries resulting from the release of proteolytic
histamine-like enzymes [37,
45,
46]. The intensity of the
erythema increases with the dose. However, the reaction is often faint, is
only briefly present, and probably goes unnoticed in many cases because no
particular attention is paid to it. If observed, this finding can serve as a
warning that a certain threshold dose has been exceeded.
Responses Beginning 1-2 Weeks After Irradiation
A second hyperemic phase, the main erythematous reaction (main erythema),
begins about 10 days after a dose of about 6 Gy and earlier when doses are
very high. Its intensity, which is also dose-dependent, reaches a peak around
the 14th day. The skin becomes warm and edematous. The patient may complain of
burning, tenderness, and itching. The main erythema represents a secondary
inflammatory reaction to damage to the proliferating cells at the basal cell
layer of the epidermis. If the dose is not much greater than the threshold,
the erythema fades after 4 weeks. Figure
1A is an example of an erythema, shown at 3 weeks after
radiofrequency cardiac catheter ablation. The patient was exposed to about 20
min of fluoroscopy with her elbow about 20-25 cm from the X-ray source. The
circular port of the X-ray system defined the sharply demarcated border of the
injury.
|
Responses Beginning About 3 Weeks After Irradiation
Epilation (hair loss) results from depletion of the germinal layers of hair
follicles. Single doses of 3-6 Gy might result in temporary loss of hair after
about 3 weeks [37]. Regrowth
occurs after approximately 8-12 weeks
[37,
47]. New hair may be thinner
and more sparse and can occasionally show a different degree of pigmentation
[41]. Doses in excess of 7 Gy
may irreversibly damage the hair follicle, and permanent epilation of the
affected follicles ensues. Huda and Peters
[25] describe such hair loss
after a neurointerventional procedure.
Sebaceous glands are as sensitive to radiation as hair follicles, whereas sweat glands are somewhat more resistant. Because of the lack of secretions from these glands, the patient may complain of dry and scaly skin [41, 48].
Radiation doses below the threshold that is lethal to epidermal cells may stimulate melanocytes to produce more pigment. After single doses of greater than 10 Gy, a prolonged hyperpigmentation lasting weeks to months may occur (Fig. 2). The hyperpigmentation gradually fades during the following months but sometimes persists indefinitely. At higher doses, melanocytes will be killed, and an area of hypo- or depigmentation will result. Often, hyper- and hypopigmentation can be observed in the same lesion. For example, an irradiated field can have a central area of hypopigmentation with margins of hyperpigmented skin. This pattern is also seen after healing of an area of dermal ulceration [39, 41] (Fig. 3).
|
|
Responses Beginning About 1 Month After Irradiation
If the radiation dose exceeds about 14 Gy, the main erythema may progress
to dry desquamation of the skin. The erythematous skin is then covered with
scales and flakes of corneum, similar to the aftereffects of a sunburn. If the
radiation dose is even higher (
18 Gy), blistering and sloughing of the
superficial skin (moist desquamation) occurs
(Fig. 4). There is continuous
weeping of serum from the deep cutaneous layers. This weeping is associated
with considerable pain and discomfort and exposes the skin to infection.
Topical antibiotics and sterile dressings are required prophylactically
[49]. Histologically, the
proliferative cells in the basal layer of the epidermis are damaged and their
number is reduced. The time delay to observe skin desquamation is
approximately the same time that differentiating basal cells take to migrate
to the stratum corneum epidermis
[46].
|
Responses Beginning About 6 Weeks After Irradiation
One or two weeks after the onset of desquamation, epithelial regeneration
occurs from the margins of the lesion and from surviving basal cells. Size of
the radiation field, and thus the size of the injury, is a factor. For all but
very small fields, regeneration is prolonged, exposing tissues to the risk of
secondary ulceration [40].
Endothelial swelling and proliferation result in arteriolar obstruction and
compromise the microcirculation. The microvascular damage causes a relative
ischemia in the irradiated area. Healing is delayed, and the developing
epidermis is typically reduced in thickness
[41]. When skin desquamation
is severe and protracted, dehydration and infection can easily complicate
healing. Secondary ulceration (Fig.
5) may also be precipitated by trivial injury to the healed but
fragile skin. Infection leads to additional skin breakdown, which further
complicates healing.
|
Responses Beginning About 8-10 Weeks After Irradiation
A third, late phase of erythema may develop 8-10 weeks after irradiation.
The threshold for a single dose has been estimated as 15 Gy or greater for
this effect to occur. This phase of erythema is associated with a dusky or
mauve skin discoloration
[37].
Responses Beginning About 10-16 Weeks After Irradiation
Microvascular damage and an overall reduction in capillary density lead to
progressive vascular insufficiency of the dermis. As a result, ischemic dermal
necrosis (Fig. 1B) may ensue at
10-16 weeks after exposure with a suggested threshold dose of 18 Gy. The
damage becomes more extensive with higher doses.
|
Prolonged Ulceration
Radiation ulcers that have healed over prior weeks recur even without
infection, often precipitated by trivial trauma, thermal injury, or exposure
to ultraviolet light. These ulcers have a tendency to recur multiple times in
the following months or years and may heal over a long, protracted course.
Rosenthal et al. [17] report
such healing characteristics in a woman who underwent radiofrequency catheter
ablation.
Some radiation ulcers never heal completely but break down intermittently instead [47]. Progression of the ulcer may ensue and can be extensive, exposing deep tissues such as tendons, muscles, or bones (Figs. 1C and 6D). A number of radiation-induced ulcers, lasting more than 6 months to years after the interventional procedure, are described in the literature. Figures 6A,6B,6C,6D (Table 2, patient 14) show the progression of an injury from superficial ulceration to deep tissue necrosis over a period of 22 months after a series of transjugular intrahepatic protosystemic shunt procedures. Injuries that are advanced to this stage require surgical excision and grafting [49] (Fig. 6E).
|
|
|
|
|
|
Responses Beginning About 12 Weeks After Irradiation
A common late consequence after a pronounced main erythema, especially when
the erythema is associated with moist desquamation, is dermal atrophy
(Fig. 7), which may develop as
early as 3 months after the injury and is seen in animal experiments to
progress in two phases [40].
In the first phase, the dermis becomes hypoplastic and the epidermis is
reduced to a few cell layers. Hair follicles disappear. Scattered focal
deposition of melanin may give the skin a discolored, poikilodermic appearance
[41]
(Fig. 3).
|
Subcutaneous induration is seen in the late phase of radiodermatitis. The induration commonly progresses with time (Fig. 8). The loose stromal net of the epidermis and the adipose tissues of the subcutis are gradually replaced by dense and fibrous tissue. The skin and subcutaneous fat feel wooden on palpation and are tender. The patient tries to avoid movement that might stress the area [41]. If subcutaneous induration develops in the vicinity of a joint, permanent restriction of movement can result (Fig. 8).
|
Responses Beginning About 1 Year After Irradiation
Late skin changes result from damage to deeper layers of the skin, mainly
to the dermis. A second phase of dermal atrophy may be observed
[40]. Atrophy gradually
progressing for about 4 years has been described
[46].
After doses greater than about 10 Gy, an atypical dilatation of superficial dermal capillaries (telangiectasia) develops (Figs. 3 and 8). The delay between exposure and occurrence is often cited as 1 year but has been noted a few months after some interventional procedures. Telangiectasias often increase as time progresses, sometimes for more than 10 years. A clear doseeffect relationship has been shown [50, 51].
When the relatively fibrous, avascular dermis cannot support the atrophic epidermis, late dermal necrosis may ensue [46]. Late dermal necrosis can occur after a long latent period of more than a year without any history of exudative dermatitis [41] (Fig. 9). The presumed threshold dose of 12 Gy is less than the threshold dose for the earlier-occurring moist desquamation, secondary ulceration, or ischemic dermal necrosis. The incidence of necrosis is thought to reach a peak in the third or fourth year [52].
|
|
|
|---|
|
|
|---|
A variety of reports have been published that suggest a correlation between exaggerated reactions after radiotherapy and connective tissue diseases, especially scleroderma, systemic and discoid lupus erythematosus, and mixed connective tissue disease [24]. Although a causative relationship for these rare observations is assumed, definite evidence is lacking. Diabetes mellitus and hyperthyroidism have also been associated with increased skin response to irradiation [36, 41, 55]. Wagner et al. [24] describe a patient with multiple health problems, including mixed connective tissue disease and diabetes mellitus, who underwent a transjugular intrahepatic portosystemic shunt procedure and later developed a severe necrotic ulceration. Patients carrying the homozygous form of the ataxia telangiectasia gene are also known to exhibit significant hypersensitivity to radiation [36, 42].
Skin sensitivity to radiation can be increased by various chemotherapeutic agents, such as actinomycin D, adriamycin, bleomycin, 5-fluorouracil, and methotrexate [36, 41, 56]. An early reaction that has healed over time can even manifest itself again in the same skin area when actinomycin D is given some weeks or months after the irradiation. This effect is known as a recall reaction. A similar reaction has been described in one patient after simvastatin administration [57]. Ciprofibrate, a fibric acid derivative used for the treatment of hyperlipidemia (not available in the United States), has been recently suggested to play a role in radiation-induced skin injury [9]. The patient in this case, however, also had lupus erythematosus, which may have contributed to the event, although the authors of the report noted that the disease could not be stimulated by ultraviolet radiation at that time.
Diagnosis of Radiation-Induced Skin Injury
|
|
|---|
Patients usually do not return to the physician who initially performed the procedure when they seek medical advice for their skin problem [30]. Usually they present at some stage to a dermatologist but do not give a history of prior fluoroscopy because they assume it is irrelevant for the complaint or have forgotten about it. This fact is especially true when there is a significant latent period. The physician will not be given the correct history indicating the cause of the lesion unless the physician specifically asks. In some cases, even if the patient mentions prior fluoroscopy, the dermatologist has disregarded fluoroscopy as a possible cause because of lack of experience with the high doses from these procedures. In our review of 73 patients [30], an initial diagnosis of a fixed drug eruption, morphea (circumscribed cutaneous scleroderma), contact dermatitis, viral or bacterial infection, or a spider bite was made, [7, 11, 12, 24], including four from this report. Consequently, the correct diagnosis was delayed. In some cases the correct diagnosis was made after a delay of 2 years [13] (Table 2, patient 14) and 5-6 years [4] after the first appearance of the lesion.
A skin biopsy was taken in 27 patients to confirm the diagnosis [30]. However, as previously stated, the diagnosis can be made from a careful medical history and the appearance of the lesion. A biopsy may be helpful if other skin conditions must be considered; however, biopsy is not always necessary. Pezzano et al. [15] discourage skin biopsies because they leave a defect that heals poorly and that can result in a chronic ulcer. We concur with this advice.
Conclusions and Recommendations
|
|
|---|
Biopsy is frequently performed. However, the results are not pathognomonic for radiation changes. Fluoroscopy-induced injuries can be recognized by the location of the injury as being congruent to the entrance of the X-ray beam and by the temporal pattern of the injury in relation to the fluoroscopy. Additionally, the injury often shows well-defined borders, which occur when the beam is not moved or resized during prolonged fluoroscopy over one site. A biopsy is usually not necessary and is not recommended because it may result in a nonhealing ulcer.
Some patients may be at greater risk for injury because of preexisting health conditions such as collagen vascular disease, diabetes mellitus, or ataxia telangiectasia, or because of a high radiation dose from a previous procedure. Good communication with the patient is essential. Interviewing the patient for potential high-risk conditions before a procedure is recommended, as is appropriate counseling. A short skin examination should be considered for patients who have had previous procedures. Further irradiation of any previous injury should be kept to a practical minimum and the patient counseled appropriately.
If a procedure is prolonged or the dose to the skin is known to be high, the patient should be advised to examine him- or herself about 2-3 weeks after the procedure to look for skin changes and to contact the interventionalist if any are observed. This information is not only good for patient care, it also assists in quality control because it indicates when dose levels have reached certain thresholds.
|
|
|---|
This article has been cited by other articles:
![]() |
J. Domienik, S. Papierz, J. Jankowski, J. Z. Peruga, A. Werduch, and W. Religa CORRELATION OF PATIENT MAXIMUM SKIN DOSES IN CARDIAC PROCEDURES WITH VARIOUS DOSE INDICATORS Radiat Prot Dosimetry, September 25, 2008; (2008) ncn247v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Nickoloff, Z. F. Lu, A. K. Dutta, and J. C. So Radiation Dose Descriptors: BERT, COD, DAP, and Other Strange Creatures RadioGraphics, September 1, 2008; 28(5): 1439 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
A KAWABE, Y TAKEDA, and Y NAKAGIRI Reduction in patient skin dose during interventional radiology with the use of an air gap substitute Br. J. Radiol., June 1, 2008; 81(966): 474 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chida, Y. Kagaya, H. Saito, Y. Takai, S. Takahashi, S. Yamada, M. Kohzuki, and M. Zuguchi Total Entrance Skin Dose: An Effective Indicator of Maximum Radiation Dose to the Skin During Percutaneous Coronary Intervention Am. J. Roentgenol., October 1, 2007; 189(4): W224 - W227. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Einstein, K. W. Moser, R. C. Thompson, M. D. Cerqueira, and M. J. Henzlova Radiation Dose to Patients From Cardiac Diagnostic Imaging Circulation, September 11, 2007; 116(11): 1290 - 1305. [Full Text] [PDF] |
||||
![]() |
T. H. Frazier, J. B. Richardson, V. C. Fabre, and J. P. Callen Fluoroscopy-Induced Chronic Radiation Skin Injury: A Disease Perhaps Often Overlooked Arch Dermatol, May 1, 2007; 143(5): 637 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zak Mapping Ventricular Tachycardia Crit. Care Nurse, October 1, 2006; 26(5): 13 - 20. [Full Text] [PDF] |
||||
![]() |
P. Zanzonico, L. N. Rothenberg, and H. W. Strauss Radiation Exposure of Computed Tomography and Direct Intracoronary Angiography: Risk Has its Reward J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1846 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chida, H. Saito, H. Otani, M. Kohzuki, S. Takahashi, S. Yamada, K. Shirato, and M. Zuguchi Relationship between fluoroscopic time, dose-area product, body weight, and maximum radiation skin dose in cardiac interventional procedures. Am. J. Roentgenol., March 1, 2006; 186(3): 774 - 778. [Abstract] [Full Text] [PDF] |
||||